FDA Announces Proposed Collection of Information for Automated Blood Cell Separator Device Review

Summary

The Food and Drug Administration (FDA) has submitted a request for review and clearance from the Office of Management and Budget (OMB) regarding a proposed collection of information related to the Automated Blood Cell Separator Device, a medical device that separates blood cells using centrifugal or filtration principles, as mandated by the Paperwork Reduction Act of 1995.